BTL-899
Sponsors
BTL Industries Ltd.
Conditions
Adipose Tissue ReductionBack PainFat BurnFat DisorderImprovement of Abdomen AppearanceMuscle Weakness
Unknown Phase
Effect of the BTL-899 Therapy for Non-invasive Lipolysis and Circumference Reduction of Abdomen
CompletedNCT03270150
Start: 2017-09-01End: 2018-10-03Updated: 2023-04-12
Clinical Evaluation of the BTL-899 Device for Non-invasive Lipolysis on Human Fat Tissue
CompletedNCT03923855
Start: 2019-05-01End: 2019-10-07Updated: 2019-12-20
Effect of the BTL-899 Therapy for Non-invasive Lipolysis and Circumference Reduction of Abdomen When Compared to a Sham Treatment
NCT04000945
Start: 2018-12-03End: 2019-12-31Updated: 2019-06-27
Non-invasive Lipolysis on Human Thighs and Saddlebags
CompletedNCT04221646
Start: 2020-01-28End: 2020-11-13Updated: 2020-11-25
rPMS and Radiofrequency for Abdominal Toning and Reduction of Subcutaneous Fat
CompletedNCT04587986
Start: 2019-07-30End: 2021-03-16Updated: 2021-04-01
Non-invasive Lipolysis and Improvement of Muscle Tone in Inner Thighs
CompletedNCT04596228
Start: 2020-10-15End: 2021-07-06Updated: 2021-11-04
Non-invasive Lipolysis and Improvement of Muscle Tone in Upper Arms
CompletedNCT04596241
Start: 2020-10-05End: 2022-02-10Updated: 2022-08-29
Fat Reduction and Muscle Toning of Thighs
CompletedNCT04599257
Start: 2020-09-15End: 2022-01-20Updated: 2022-02-09
Effect of BTL-899 Device for Non-invasive Lipolysis on Human Upper Arms
CompletedNCT04643275
Start: 2020-10-15End: 2021-09-02Updated: 2021-09-09
Histological Evaluation of BTL-899 Device´s Effect on Fat Tissue
CompletedNCT05139745
Start: 2021-10-11End: 2022-08-11Updated: 2022-08-26
Non-invasive Lipolysis and Improvement of Muscle Tone in Lateral Abdomen
CompletedNCT05540080
Start: 2022-06-10End: 2023-10-11Updated: 2024-04-26
Combination Treatment With BTL-899 and HPM-6000UF Devices II
CompletedNCT05713864
Start: 2022-03-08End: 2022-11-30Updated: 2023-04-13
Safety and Efficacy of the BTL-043 and BTL-899 Devices in Alleviating Back Pain
Active, not recruitingNCT07700433
Start: 2025-12-08End: 2026-12-01Target: 60Updated: 2026-07-14